345 related articles for article (PubMed ID: 37050086)
1. The Anti-Inflammatory Activity of
Nicoletti M
Plants (Basel); 2023 Mar; 12(7):. PubMed ID: 37050086
[TBL] [Abstract][Full Text] [Related]
2. Viscum album L. homogenizer-assisted and ultrasound-assisted extracts as potential sources of bioactive compounds.
Stefanucci A; Zengin G; Llorent-Martinez EJ; Dimmito MP; Della Valle A; Pieretti S; Ak G; Sinan KI; Mollica A
J Food Biochem; 2020 Sep; 44(9):e13377. PubMed ID: 32713043
[TBL] [Abstract][Full Text] [Related]
3. Phytochemical profile and therapeutic potential of Viscum album L.
Nazaruk J; Orlikowski P
Nat Prod Res; 2016; 30(4):373-85. PubMed ID: 25813519
[TBL] [Abstract][Full Text] [Related]
4. The Antioxidant Activity of Mistletoes (
Nicoletti M
Plants (Basel); 2023 Jul; 12(14):. PubMed ID: 37514321
[TBL] [Abstract][Full Text] [Related]
5. Phytochemical screening and effect of Viscum album L. on monoamine oxidase A and B activity and serotonin, dopamine and serotonin receptor 5-HTR1A levels in Galleria mellonealla (Lepidoptera).
Szurpnicka A; Wrońska AK; Bus K; Kozińska A; Jabłczyńska R; Szterk A; Lubelska K
J Ethnopharmacol; 2022 Nov; 298():115604. PubMed ID: 35944736
[TBL] [Abstract][Full Text] [Related]
6. Viscotoxin and lectin content in foliage and fruit of Viscum album L. on the main host trees of Hyrcanian forests.
Yousefvand S; Fattahi F; Hosseini SM; Urech K; Schaller G
Sci Rep; 2022 Jun; 12(1):10383. PubMed ID: 35725801
[TBL] [Abstract][Full Text] [Related]
7. [Mistletoe in the treatment of cancer patients].
Rostock M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 May; 63(5):535-540. PubMed ID: 32211937
[TBL] [Abstract][Full Text] [Related]
8. Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts.
Holandino C; Melo MNO; Oliveira AP; Batista JVDC; Capella MAM; Garrett R; Grazi M; Ramm H; Torre CD; Schaller G; Urech K; Weissenstein U; Baumgartner S
BMC Complement Med Ther; 2020 Jul; 20(1):215. PubMed ID: 32646417
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
10. Phytochemical Profile and Antioxidant Capacity of
Kleszken E; Purcarea C; Pallag A; Ranga F; Memete AR; Miere Groza F; Vicas SI
Plants (Basel); 2022 Nov; 11(22):. PubMed ID: 36432750
[No Abstract] [Full Text] [Related]
11. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
12. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
Felenda JE; Turek C; Stintzing FC
J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
[TBL] [Abstract][Full Text] [Related]
14. Proteomic fingerprinting of mistletoe (Viscum album L.) via combinatorial peptide ligand libraries and mass spectrometry analysis.
Vergara-Barberán M; Lerma-García MJ; Nicoletti M; Simó-Alfonso EF; Herrero-Martínez JM; Fasoli E; Righetti PG
J Proteomics; 2017 Jul; 164():52-58. PubMed ID: 28571969
[TBL] [Abstract][Full Text] [Related]
15. Untargeted metabolomics approach to discriminate mistletoe commercial products.
Vanhaverbeke C; Touboul D; Elie N; Prévost M; Meunier C; Michelland S; Cunin V; Ma L; Vermijlen D; Delporte C; Pochet S; Le Gouellec A; Sève M; Van Antwerpen P; Souard F
Sci Rep; 2021 Jul; 11(1):14205. PubMed ID: 34244531
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of mistletoe in CNS-related neurological disorders and the chemical composition of Viscum species.
Szurpnicka A; Zjawiony JK; Szterk A
J Ethnopharmacol; 2019 Mar; 231():241-252. PubMed ID: 30458281
[TBL] [Abstract][Full Text] [Related]
17. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
Bar-Sela G; Gershony A; Haim N
Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
[TBL] [Abstract][Full Text] [Related]
18. [Lectins in Viscum:a progress review].
Li JQ; Yang B
Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(14):3551-3559. PubMed ID: 34402277
[TBL] [Abstract][Full Text] [Related]
19.
Klingemann H
Front Vet Sci; 2023; 10():1285354. PubMed ID: 38234984
[TBL] [Abstract][Full Text] [Related]
20. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]